Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
Seelos Therapeutics, Inc. (SEELQ) had Earnings per Share (EPS) (Basic) of $10.88 for the most recently reported fiscal quarter, ending 2024-06-30.
| Income Statement Financials | |
$0.38M |
|
$1.71M |
|
-- |
|
$0.38M |
|
$3.52M |
|
$-3.14M |
|
$4.85M |
|
$1.71M |
|
$1.71M |
|
$1.71M |
|
$1.71M |
|
$1.71M |
|
$1.71M |
|
$-3.14M |
|
$-3.12M |
|
0.16M |
|
0.16M |
|
|
Earnings per Share (EPS) (Basic) |
$10.88 |
$1.92 |
|
| Balance Sheet Financials | |
$2.33M |
|
-- |
|
$0.05M |
|
$2.38M |
|
$30.51M |
|
-- |
|
-- |
|
$30.51M |
|
$-28.13M |
|
$-28.13M |
|
$-28.13M |
|
0.21M |
|
| Cash Flow Statement Financials | |
$-5.61M |
|
-- |
|
$2.91M |
|
$3.00M |
|
$0.29M |
|
$-2.70M |
|
$1.83M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.08 |
|
-- |
|
-- |
|
-- |
|
-0.36 |
|
100.00% |
|
-834.84% |
|
-834.84% |
|
-- |
|
454.79% |
|
454.79% |
|
$-5.61M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
-- |
|
2.00 |
|
45.00 |
|
-6.08% |
|
-6.08% |
|
71.82% |
|
-6.08% |
|
$-135.50 |
|
$-35.72 |
|
$-35.72 |
|